Shuaicheng Wang

Analytical Characterization of an Enzyme-Linked Immunosorbent Assay for the Measurement of Transforming Growth Factor β1 in Human Plasma.

K. Pitts, M. Man, K. Benhadji, 2018, The journal of applied laboratory medicine.

Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib

V. Paradis, G. Giannelli, E. Raymond, 2020, PloS one.

Subgroups from regression trees with adjustment for prognostic effects and postselection inference

W. Loh, M. Man, Shuaicheng Wang, 2019, Statistics in medicine.

TGFβ receptor inhibitor galunisertib is linked to inflammation- and remodeling-related proteins in patients with pancreatic cancer

J. Tabernero, J. Trojan, D. Melisi, 2019, Cancer Chemotherapy and Pharmacology.

Detecting association of rare and common variants based on cross‐validation prediction error

Shuanglin Zhang, Qiuying Sha, Xinlan Yang, 2017, Genetic epidemiology.

Adaptive clustering and adaptive weighting methods to detect disease associated rare variants

Shuanglin Zhang, Q. Sha, Shuaicheng Wang, 2012, European Journal of Human Genetics.

Phase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant glioma

D. Capper, A. Wick, S. Estrem, 2020, Investigational New Drugs.

Detecting association of rare and common variants by testing an optimally weighted combination of variants with longitudinal data

Shuanglin Zhang, Qiuying Sha, Shuaicheng Wang, 2014, BMC Proceedings.